Source: BioSpace

Ce3Inc: Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO

Catalyst Clinical Research announced today that it has merged with Ce3, Inc . to expand its depth of oncology-specific therapeutic expertise. The combined company is strongly positioned to deliver oncology clinical development services to the biotechnology industry, as Ce3 has provided such services for more than 15 years. Catalys

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
CEO Avatar

Co-Founder & CEO

Holly Coulter

CEO Approval Rating

69/100

Read more